What are the causes of macrocytic erythrocytosis (enlarged red blood cells with increased red cell mass)?

Macrocytic Erythrocytosis: Primary Causes

Macrocytic erythrocytosis (enlarged red blood cells with increased red cell mass) is most commonly caused by polycythemia vera (PV), a myeloproliferative neoplasm driven by JAK2 mutations in 95% of cases, though secondary causes related to oxygen-sensing pathway defects and high-affinity hemoglobins must also be considered 1, 2.

Algorithmic Approach to Causes

Primary (Clonal) Causes

The defect originates within the bone marrow itself:

• Polycythemia Vera (PV) - The dominant primary cause

  • JAK2V617F mutation present in ~95% of cases 1
  • JAK2 exon 12 mutations in remaining cases 1
  • Diagnostic criteria require hemoglobin >18.5 g/dL (men) or >16.5 g/dL (women) plus JAK2 mutation 2
  • Bone marrow shows trilineage myeloproliferation with prominent erythroid proliferation 1
  • Serum erythropoietin levels are characteristically low 1, 2

• Primary Myelofibrosis (PMF) - Less common but can present with erythrocytosis

  • JAK2V617F in ~50% of cases 1
  • CALR mutations also diagnostic 2
  • Megakaryocyte proliferation with atypia and bone marrow fibrosis 2

Secondary (Non-Clonal) Causes

External stimuli drive red cell production 3:

Congenital/Familial Forms:

• Erythropoietin receptor (EPOR) mutations - Familial erythrocytosis type 1 with hypersensitivity to EPO 4, 5
• Oxygen-sensing pathway defects (types 2-5):
  • VHL gene loss-of-function mutations 4, 5
  • EGLN1/PHD2 loss-of-function mutations 5
  • EPAS1/HIF-2α gain-of-function mutations 5
  • EPO gene mutations 4
• High oxygen-affinity hemoglobins (types 6-8):
  • HBB, HBA1, HBA2 mutations 4, 5
  • BPGM mutations affecting 2,3-bisphosphoglycerate levels 5

Acquired Secondary Forms:

• Hypoxic conditions (chronic lung disease, high altitude, sleep apnea)
• Renal pathology with inappropriate EPO production
• EPO-secreting tumors 1

Critical Diagnostic Distinctions

The fundamental fork in the diagnostic pathway is measuring serum erythropoietin:

• Low/normal EPO → Pursue primary causes (JAK2 testing for PV) 1, 2
• Elevated EPO → Pursue secondary causes (oxygen-sensing defects, hemoglobin variants) 4, 5

Key Pitfall to Avoid

Over 70% of congenital erythrocytosis cases remain idiopathic despite known genetic causes 4. Do not assume all JAK2-negative cases with low EPO are benign - consider bone marrow biopsy to evaluate for other myeloproliferative neoplasms like PMF, which can present with erythrocytosis and carries different prognostic implications 2.

Important Clinical Context

While the question asks about "macrocytic" erythrocytosis specifically, true macrocytosis (MCV >100 fL) with erythrocytosis is uncommon. Most erythrocytosis presents with normal or even low MCV. If genuine macrocytosis is present alongside erythrocytosis, consider:

• Early myeloproliferative neoplasm with dysplastic features
• Concurrent vitamin B12/folate deficiency (though this typically causes anemia, not erythrocytosis) 6
• Alcohol use affecting both RBC size and production 6

The combination of truly enlarged RBCs with increased red cell mass should prompt immediate JAK2 mutation testing and bone marrow evaluation to exclude myeloproliferative neoplasms, as these carry significant thrombotic risk and require specific management with phlebotomy and potentially cytoreductive therapy 2.